A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Cytomegalovirus RetinitisHIV Infections

Interventions

DRUG

Globulin, Immune

DRUG

Ganciclovir

Trial Locations (1)

Georgetown Univ Med Ctr, Washington D.C.

All Listed Sponsors

lead

American National Red Cross

OTHER